{"product_id":"35dag-antibody-sc-f3978","title":"δ Sarcoglycan Antibody","description":"\u003ch2\u003eAbout the Target\u003c\/h2\u003e\u003cp\u003e35DAG is a target of interest in many antibody-based workflows. δ-Sarcoglycan is a type II transmembrane glycoprotein and a core component of the sarcoglycan complex within the dystrophin-glycoprotein complex (DGC), which stabilizes the plasma membrane in muscle cells. Structurally, it contains a short cytoplasmic N-terminus, a single transmembrane domain, an extracellular region with one N-linked glycosylation site, and a conserved cysteine-rich cluster at the C-terminus resembling epidermal growth factor-like motifs, although an alternatively spliced form lacking this region is also expressed. Depending on the literature source, 35DAG may also be discussed as delta Sarcoglycan and Delta-sarcoglycan.\u003c\/p\u003e\u003cp\u003eReported cellular context includes cell membrane, cytoplasm, cytoskeleton, and membrane, which can matter when signal is compared across treatments or changing cell states. Following 35DAG across matched perturbations can help separate abundance effects from shifts in localization, complex assembly, or pathway state.\u003c\/p\u003e\u003ch2\u003eResearch Context\u003c\/h2\u003e\u003cp\u003e35DAG is commonly interpreted in the context of cardiovascular research, and readouts are often stronger when a study separates expression changes from compartment-level redistribution. When reported signal spans cell membrane, cytoplasm, and cytoskeleton, a defined reference condition can make comparisons more interpretable across perturbations, passages, or replicate sets.\u003c\/p\u003e\u003cp\u003eConsider these angles when interpreting target-level changes:\u003c\/p\u003e\u003cul\u003e\n\u003cli\u003eapparent redistribution between cell membrane, cytoplasm, and cytoskeleton across matched conditions\u003c\/li\u003e\n\u003cli\u003echanges linked to vascular, contractile, or hemodynamic cell-state cues\u003c\/li\u003e\n\u003cli\u003eco-patterning with orthogonal markers and control conditions that clarify pathway state\u003c\/li\u003e\n\u003cli\u003etime-matched comparisons so changes reflect biology rather than handling or sampling drift\u003c\/li\u003e\n\u003c\/ul\u003e\u003ch2\u003eVariant Considerations\u003c\/h2\u003e\u003cp\u003eIf your project spans exploratory questions, the regular version offers a balanced option for establishing baseline signal behavior for 35DAG. This can help when protocols evolve over time and the goal is to compare experiments using a stable reference workflow.\u003c\/p\u003e\u003cp\u003eStandardize sampling time, control choice, and downstream analysis thresholds so apparent differences in 35DAG reflect biology rather than handling. When interpreting 35DAG, it is often useful to decide early whether the main question is overall abundance, compartmental enrichment, or context-dependent redistribution.\u003c\/p\u003e\u003cp\u003eFor multi-run studies, a shared reference condition can keep 35DAG trends easier to compare across datasets. That kind of consistency is especially helpful when follow-up work expands to new perturbations, model systems, or longitudinal collections.\u003c\/p\u003e","brand":"Selleck Chemicals","offers":[{"title":"20 µl","offer_id":57578053960025,"sku":"F3978-20UL","price":199.0,"currency_code":"EUR","in_stock":true},{"title":"100 µl","offer_id":57578053992793,"sku":"F3978-100UL","price":489.0,"currency_code":"EUR","in_stock":true},{"title":"2 × 100 µl","offer_id":57578054025561,"sku":"F3978-2X100UL","price":729.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0923\/1011\/0553\/files\/F3978-wb.gif?v=1773601588","url":"https:\/\/absource.de\/products\/35dag-antibody-sc-f3978","provider":"Absource Diagnostics","version":"1.0","type":"link"}